Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 21 to 60 years. Either male or female patients. Patients diagnosed with dyslipidemia based on any one of the following: Total cholesterol more than 200 mg per dl Triglycerides more than 150 mg per dl LDL cholesterol more than 130 mg per dl HDL cholesterol less than 40 mg per dl Patients willing to participate and able to provide written informed consent. Patients available for regular follow up during the study period.
Exclusion criteria
Exclusion criteria: Age less than 21 years or more than 60 years. Patients with uncontrolled diabetes mellitus or uncontrolled hypertension. Patients with history of cardiovascular diseases such as coronary artery disease, myocardial infarction or ischemic heart disease. Patients with renal or hepatic disorders. Patients with hypothyroidism or other secondary causes of dyslipidemia. Patients with hereditary dyslipidemia or drug induced dyslipidemia. Pregnant or lactating women. Patients with known allergy or hypersensitivity to study drugs. Patients not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in lipid profile parameters (total cholesterol, triglycerides, LDL and HDL) from baseline to end of treatmentTimepoint: Baseline, Day 15, Day 30, Day 45 and Day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of safety by liver function test and kidney function test at baseline and Day 60; assessment of body mass index changes at baseline and Day 60; assessment of clinical symptoms of Medoroga at baseline, Day 30 and Day 60Timepoint: Baseline, Day 30 and Day 60 | — |
Countries
India
Contacts
State Ayurvedic College and Hospital Lucknow